Science

Whistleblower: Purdue Pharma Continued Shady Sales Tactics for OxyContin

OUCH

Sales reps told doctors that patients could cure “pseudoaddiction” with more opioids, former staffer says.

oxyyyy_gzhiyb
GEORGE FREY/REUTERS / Reuters